Methotrexate Test Dose Use and Frequency of Laboratory Abnormalities in Patients Initiating Treatment
When initiating methotrexate in dermatology and rheumatology patients, the use of a test dose may be of limited value in detecting or preventing significant laboratory abnormalities. These findings provide support for evolving guidelines and consensus statements in dermatology regarding methotrexate test dose use.  .
Authors
- Michael J. Miller (ORCID: https://orcid.org/0000-0001-8579-1080)
- Kurt S. Wenk
- Seohyun Kim (ORCID: https://orcid.org/0000-0002-2119-6044)
- Yi‐Shin Sheu
- Xinxie Wu
Publication Details
- Journal
- Journal of Drugs in Dermatology
- Published
- 2025-10-01
- DOI
- https://doi.org/10.36849/jdd.9107
- Primary Topic
- Rheumatoid Arthritis Research and Therapies
- Type
- article
- Field-Weighted Citation Impact
- 0.00